Interleukin-6 changes tight junction permeability and intracellular phospholipid contentin a human enterocyte cell culture model

Pediatric Surgery International

Volumn 19, Issue 5, 2003, Pages 321-325

  Tazuke, Y ^a   Drongowski, R A ^a   Teitelbaum, D H ^a   Coran, A G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Epithelial permeability; Inflammatory bowel disease; Interleukin 6; Phospholipid; Proinflammatory cytokines; Secretory phospholipase A 2

Indexed keywords

INTERLEUKIN 6; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE A2; PHOSPHOLIPID;

CELL CULTURE; CELL STRAIN CACO 2; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENTERITIS; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; INFLAMMATION; INTESTINE CELL; INTESTINE MUCOSA PERMEABILITY; LIPID COMPOSITION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; ENTEROCYTES; HUMANS; INTERLEUKIN-6; INTRACELLULAR SPACE; PHOSPHOLIPIDS; TIGHT JUNCTIONS;

EID: 0042379741     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-003-1003-8     Document Type: Conference Paper

References (31)

1. Sartor RB (1994) Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 106:533-539
2. Sartor RB (1994) Cyclosporine therapy for inflammatory bowel disease. N Engl J Med 330:1897-1898
3. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, MacDermott RP, Raedler A (1993) Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94:174-181
4. Gennari R, Alexander JW, Pyles T, Hartmann S, Ogle CK (1994) Effects of antimurine interleukin-6 on bacterial translocation during gut-derived sepsis. Arch Surg 129:1191-1197
5. Kishikawa H, Miura S, Yoshida H, Hirokawa M, Nakamizo H, Higuchi H, Adachi M, Nakatsumi RC, Suzuki H, Saito H, Ishii H (2002) Transmural pressure induces IL-6 secretion by intestinal epithelial cells. Clin Exp Immunol 129:86-91
6. Molmenti EP, Ziambaras T, Perlmutter DH (1993) Evidence for an acute phase response in human intestinal epithelial cells. J Biol Chem 268:14116-14124
7. Ziambaras T, Rubin DC, Perlmutter DH (1996) Regulation of sucrase-isomaltase gene expression in human intestinal epithelial cells by inflammatory cytokines. J Biol Chem 271:1237-1242
8. Vadas P, Scott K, Smith G, Rajkovic I, Stefanski E, Schouten BD, Singh R, Pruzanski W (1992) Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock. Life Sci 50:807-811
9. Vadas P (1984) Elevated plasma phospholipase A2 levels: correlation with the hemodynamic and pulmonary changes in gram-negative septic shock. J Lab Clin Med 104:873-881
10. Otamiri T, Franzen L, Lindmark D, Tagesson C (1987) Increased phospholipase A2 and decreased lysophospholipase activity in the small intestinal mucosa after ischaemia and revascularisation. Gut 28:1445-1453
11. Tagesson C, Telemo E, Ekstrom G, Westrom B (1987) Development of phospholipase A2 and lysophosphatidylcholine metabolising enzyme activities in the neonatal rat intestine. Gut 28:822-828
12. Sawai T, Drongowski RA, Lampman RW, Coran AG, Harmon CM (2001) The effect of phospholipids and fatty acids on tight-junction permeability and bacterial translocation. Pediatr Surg Int 17:269-274
13. Holch JLM, Sloane Stanley GH (1959) A simple method for the isolation and purification of total lipids from animal tissues. J Biochem 226:497-509
14. Weinhold PAVC (1965) Phospholipid metabolism in the liver and lung of rats during development. Biochim Biophys Acta 106:540-550
15. Abe A, Gregory S, Lee L, Killen PD, Brady RO, Kulkarni A, Shayman JA (2000) Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation. J Clin Invest 105:1563-1571
16. Brown KA, Back SJ, Ruchelli ED, Markowitz J, Mascarenhas M, Verma R, Piccoli DA, Baldassano RN (2002) Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients. Am J Gastroenterol 97:2603-2608
17. Murakami M, Kuwata H, Amakasu Y, Shimbara S, Nakatani Y, Atsumi G, Kudo I (1997) Prostaglandin E2 amplifies cytosolic phospholipase A2- and cyclooxygenase-2-dependent delayed prostaglandin E2 generation in mouse osteoblastic cells. Enhancement by secretory phospholipase A2. J Biol Chem 272:19891-19897
18. Balsinde J, Balboa MA, Li WH, Llopis J, Dennis EA (2000) Cellular regulation of cytosolic group IV phospholipase A2 by phosphatidylinositol bisphosphate levels. J Immunol 164:5398-5402
19. Pruzanski W, Keystone EC, Sternby B, Bombardier C, Snow KM, Vadas P (1988) Serum phospholipase A2 correlates with disease activity in rheumatoid arthritis. J Rheumatol 15:1351-1355
20. Minami T, Tojo H, Shinomura Y, Komatsubara T, Matsuzawa Y, Okamoto M (1993) Elevation of phospholipase A2 protein in sera of patients with Crohn's disease and ulcerative colitis. Am J Gastroenterol 88:1076-1080
21. Minami T, Tojo H, Shinomura Y, Matsuzawa Y, Okamoto M (1994) Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Gut 35:1593-1598
22. Minami T, Tojo H, Shinomura Y, Tarui S, Okamoto M (1992) Raised serum activity of phospholipase A2 immunochemically related to group II enzyme in inflammatory bowel disease: its correlation with disease activity of Crohn's disease and ulcerative colitis. Gut 33:914-921
23. Yamashita S, Yamashita J, Ogawa M (1994) Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency. Br J Cancer 69:1166-1170
24. Minami T, Zushi S, Shinomura Y, Matsuzawa Y (1996) Phospholipase A2 stimulation of rat intestinal epithelial cell (IEC-6) migration. Am J Physiol 271:G664-G668
25. Longo WE, Grossmann EM, Erickson B, Panesar N, Mazuski JE, Kaminski DL (1999) The effect of phospholipase A2 inhibitors on proliferation and apoptosis of murine intestinal cells. J Surg Res 84:51-56
26. Bertsch T, Banks RE, Forbes MA, Aufenanger J, Storr M, Illingworth JM, Perren TJ, Selby PJ, Kattermann R (1996) Phospholipase A2 activity in serum is induced during treatment with recombinant human interleukin-6 in patients with cancer. Ann Clin Biochem 33:565-567
27. Crowl RM, Stoller TJ, Conroy RR, Stoner CR (1991) Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 266:2647-2651
28. Homan R, Hamelehle KL (1998) Phospholipase A2 relieves phosphatidylcholine inhibition of micellar cholesterol absorption and transport by human intestinal cell line Caco-2. J Lipid Res 39:1197-1209
29. Hannun YA (1994) The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269:3125-3128
30. Kolesnick R (2002) The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest 110:3-8
31. Dobrowsky RT, Kolesnick RN (2001) Analysis of sphingomyelin and ceramide levels and the enzymes regulating their metabolism in response to cell stress. Methods Cell Biol 66:135-165